- Home
- Publications
- Publication Search
- Publication Details
Title
Wnt Signaling in Gynecologic Malignancies
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 12, Pages 4272
Publisher
MDPI AG
Online
2020-06-17
DOI
10.3390/ijms21124272
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis
- (2020) Marwa Asem et al. CANCER RESEARCH
- Proteogenomic Characterization of Endometrial Carcinoma
- (2020) Yongchao Dou et al. CELL
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Antiepileptic Drug Carbamazepine Binds to a Novel Pocket on the Wnt Receptor Frizzled-8
- (2020) Yuguang Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expression of Wnt pathway molecules is associated with disease outcome in metastatic high-grade serous carcinoma
- (2020) Michal Chehover et al. VIRCHOWS ARCHIV
- Inhibition of Wnt signalling pathway by XAV939 enhances radiosensitivity in human cervical cancer HeLa cells
- (2020) Jinhua Zhang et al. Artificial Cells Nanomedicine and Biotechnology
- Aberrant WNT/CTNNB1 Signaling as a Therapeutic Target in Human Breast Cancer: Weighing the Evidence
- (2020) Emma H. van Schie et al. Frontiers in Cell and Developmental Biology
- Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer
- (2020) Ilaria Betella et al. GYNECOLOGIC ONCOLOGY
- Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment
- (2020) Whitney N. Goldsberry et al. Cancers
- WNT/β-catenin pathway activation correlates with immune exclusion across human cancers
- (2019) Jason J. Luke et al. CLINICAL CANCER RESEARCH
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
- (2019) Lorenzo Castagnoli et al. ONCOGENE
- High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
- (2019) Michael-Antony Lisio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carcinoma
- (2019) Danielle C. Costigan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers
- (2019) Marisa R. Moroney et al. GYNECOLOGIC ONCOLOGY
- N6-methylation of adenosine (m6A) of FZD10 mRNA contributes to PARP inhibitor resistance
- (2019) Takeshi Fukumoto et al. CANCER RESEARCH
- Convergence of Wnt and Notch signaling controls ovarian cancer cell survival
- (2019) Sebastián Bocchicchio et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SALL4 promotes the tumorigenicity of cervical cancer cells through activation of Wnt/β‐catenin pathway via CTNNB1
- (2019) Mei Chen et al. CANCER SCIENCE
- The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice
- (2019) Hiroyasu Okazaki et al. EXPERIMENTAL LUNG RESEARCH
- WNT5A gene and protein expression in endometrial cancer
- (2019) Tomasz Wasniewski et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Activation of Wnt signaling promotes olaparib resistant ovarian cancer
- (2019) Tomomi M. Yamamoto et al. MOLECULAR CARCINOGENESIS
- The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models
- (2019) Betty Y. Tam et al. CANCER LETTERS
- A phase 1b dose escalation study of ipafricept (OMP 54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
- (2019) Kathleen N. Moore et al. GYNECOLOGIC ONCOLOGY
- Toward understanding the origin and evolution of cellular organisms
- (2019) Minoru Kanehisa PROTEIN SCIENCE
- Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer
- (2019) Xiaohong Ruan et al. Molecular Therapy-Oncolytics
- Wnt family member 4 (WNT4) and WNT3A activate cell-autonomous Wnt signaling independent of porcupine O-acyltransferase or Wnt secretion
- (2019) Deviyani M. Rao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
- (2019) Zachary L. Watson et al. Clinical Epigenetics
- Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
- (2019) Teeuwssen et al. Journal of Clinical Medicine
- Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination—Review of Current Perspectives
- (2019) Chee Kai Chan et al. Journal of Oncology
- Pyrvinium pamoate inhibits proliferation and invasion of human endometriotic stromal cells
- (2019) A Karamian et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- IL‐8 promotes cell migration through regulating EMT by activating the Wnt/β‐catenin pathway in ovarian cancer
- (2019) Jirui Wen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
- (2019) Vu Hong Loan Nguyen et al. Journal of Ovarian Research
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- Oestrogen fuels the growth of endometrial hyperplastic lesions initiated by overactive Wnt/β-catenin signalling
- (2018) Jyoti Goad et al. CARCINOGENESIS
- Wnt signalling: conquering complexity
- (2018) Katrin E. Wiese et al. DEVELOPMENT
- Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε
- (2018) Balbina García-Reyes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association
- (2018) Grace Kim et al. MODERN PATHOLOGY
- Is β-Catenin a Druggable Target for Cancer Therapy?
- (2018) Can Cui et al. TRENDS IN BIOCHEMICAL SCIENCES
- KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer
- (2018) Yaqin Wu et al. OncoTargets and Therapy
- SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer
- (2018) Lu Li et al. Cell Death & Disease
- DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/β-catenin pathway via GSK3β
- (2018) Xiao-Fang Liu et al. Cell Death & Disease
- Mechanisms of Wnt signaling and control
- (2018) Stephanie Grainger et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Wnt signaling in cervical cancer?
- (2018) Min Yang et al. Journal of Cancer
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016
- (2018) et al. JAMA Oncology
- A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy
- (2018) Jiahui Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target
- (2018) Amy Coopes et al. ENDOCRINE-RELATED CANCER
- A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties
- (2018) Zvezdan Pavlovic et al. mAbs
- Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling
- (2018) Geyan Wu et al. CLINICAL CANCER RESEARCH
- Genomic characterization of cervical cancer based on human papillomavirus status
- (2018) Liya Zhang et al. GYNECOLOGIC ONCOLOGY
- Cancer of the cervix uteri
- (2018) Neerja Bhatla et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- HPV-18 E6 Oncoprotein and Its Spliced Isoform E6*I Regulate the Wnt/β-Catenin Cell Signaling Pathway through the TCF-4 Transcriptional Factor
- (2018) J. Muñoz-Bello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long noncoding RNA HOTAIR knockdown inhibits autophagy and epithelial-mesenchymal transition through the Wnt signaling pathway in radioresistant human cervical cancer HeLa cells
- (2018) Xinggang Guo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions
- (2018) Phuong N. Le et al. MOLECULAR CARCINOGENESIS
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of R-spondin 1 through activating Wnt/β-catenin in the growth, survival and migration of ovarian cancer cells
- (2018) Qiong Liu et al. GENE
- PARP inhibitors: Clinical utility and possibilities of overcoming resistance
- (2017) Benjamin G. Bitler et al. GYNECOLOGIC ONCOLOGY
- Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
- (2017) Elizabeth M Swisher et al. LANCET ONCOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
- (2017) Katherine C Kurnit et al. MODERN PATHOLOGY
- E6 proteins of α and β cutaneous HPV types differ in their ability to potentiate Wnt signaling
- (2017) Sophia Sominsky et al. VIROLOGY
- Clinical significance and biological role of Wnt10a in ovarian cancer
- (2017) Ping Li et al. Oncology Letters
- DACT1 Overexpression in type I ovarian cancer inhibits malignant expansion and cis-platinum resistance by modulating canonical Wnt signalling and autophagy
- (2017) Ruo-nan Li et al. Scientific Reports
- Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy
- (2017) Chongyuan Zhang et al. MEDICAL SCIENCE MONITOR
- Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
- (2017) Kiminori Kimura et al. EBioMedicine
- Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines
- (2017) A. Deshmukh et al. Scientific Reports
- Endometrial cancer: Not your grandmother's cancer
- (2016) Jessica N. McAlpine et al. CANCER
- Advances in diagnosis and treatment of metastatic cervical cancer
- (2016) Haoran Li et al. Journal of Gynecologic Oncology
- Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer
- (2016) Tze-Kiong Er et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
- (2016) Yi Du et al. NATURE MEDICINE
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling
- (2016) S Bernaudo et al. ONCOGENE
- Wnt-11 overexpression promoting the invasion of cervical cancer cells
- (2016) Heng Wei et al. TUMOR BIOLOGY
- Expression of WNT genes in cervical cancer-derived cells: Implication of WNT7A in cell proliferation and migration
- (2015) Moisés Ramos-Solano et al. EXPERIMENTAL CELL RESEARCH
- Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
- (2015) Ellen Stelloo et al. MODERN PATHOLOGY
- Tankyrase Inhibition Causes Reversible Intestinal Toxicity in Mice with a Therapeutic Index < 1
- (2015) Yu Zhong et al. TOXICOLOGIC PATHOLOGY
- Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins
- (2015) Jesus Bello et al. Viruses-Basel
- Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
- (2015) Anil Belur Nagaraj et al. Oncotarget
- Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively
- (2015) Kensaku Shojima et al. Scientific Reports
- Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling
- (2014) Yu Fan et al. FEBS Journal
- β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers
- (2014) Andrea Myers et al. GYNECOLOGIC ONCOLOGY
- Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma
- (2014) Yuexin Liu et al. JNCI-Journal of the National Cancer Institute
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Clinical significance of Wnt-11 and squamous cell carcinoma antigen expression in cervical cancer
- (2014) Heng Wei et al. MEDICAL ONCOLOGY
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- HPV16 E6 and E6AP differentially cooperate to stimulate or augment Wnt signaling
- (2014) Sophia Sominsky et al. VIROLOGY
- The Wnt/β-catenin pathway in ovarian cancer: A review
- (2013) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Overexpression of Wnt7a Is Associated With Tumor Progression and Unfavorable Prognosis in Endometrial Cancer
- (2013) Yunduo Liu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway
- (2013) Xiao-Hong Tian et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
- (2012) J. S. Nielsen et al. CLINICAL CANCER RESEARCH
- Use of mutation profiles to refine the classification of endometrial carcinomas
- (2012) Melissa K McConechy et al. JOURNAL OF PATHOLOGY
- Correction: FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
- (2012) Sara A. Byron et al. PLoS One
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence
- (2011) B. G. Bitler et al. CANCER RESEARCH
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Beta-Catenin Accelerates Human Papilloma Virus Type-16 Mediated Cervical Carcinogenesis in Transgenic Mice
- (2011) Gülay Bulut et al. PLoS One
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
- (2010) Curtis A Thorne et al. Nature Chemical Biology
- Progesterone Inhibition of Wnt/ -Catenin Signaling in Normal Endometrium and Endometrial Cancer
- (2009) Y. Wang et al. CLINICAL CANCER RESEARCH
- Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling
- (2009) Amanda Mikels et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- β-catenin mediates glandular formation and dysregulation of β-catenin induces hyperplasia formation in the murine uterus
- (2008) J-W Jeong et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started